| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
,§
Departments of
*
Membrane Biochemistry and
Enteric Infections, Walter Reed Army Institute of Research, Washington, DC 20307;
IOMAI Corporation, Washington, DC 20307; and
§
Intellivax, Baltimore, MD 21227
We recently reported that application of cholera toxin (CT) to the skin results in transcutaneous immunization and induces a systemic Ab response to both CT and coadministered Ags. In this paper, we demonstrate antitoxin IgG and IgA Abs in sera, lung washes, and stool samples from immunized mice as well as a broad spectrum of IgG subclasses (IgG1, IgG2a, IgG2b, and IgG3) in the sera. Mice immunized with CT by the transcutaneous route exhibited significant protection from intranasal challenge with a lethal dose of CT. Thus, clinically relevant immunity against mucosal toxin challenge can be achieved via the transcutaneous route.
This article has been cited by other articles:
|
|
 |
|
  S.-Y. Chang, H.-R. Cha, O. Igarashi, P. D. Rennert, A. Kissenpfennig, B. Malissen, M. Nanno, H. Kiyono, and M.-N. Kweon Cutting Edge: Langerin+ Dendritic Cells in the Mesenteric Lymph Node Set the Stage for Skin and Gut Immune System Cross-Talk J. Immunol., April 1, 2008; 180(7): 4361 - 4365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhu, J. Yu, Z. Yang, K. Davis, H. Rios, B. Wang, G. Glenn, and E. C. Boedeker Protection against Shiga Toxin-Producing Escherichia coli Infection by Transcutaneous Immunization with Shiga Toxin Subunit B Clin. Vaccine Immunol., February 1, 2008; 15(2): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stoitzner, L. K. Green, J. Y. Jung, K. M. Price, C. H. Tripp, B. Malissen, A. Kissenpfennig, I. F. Hermans, and F. Ronchese Tumor Immunotherapy by Epicutaneous Immunization Requires Langerhans Cells J. Immunol., February 1, 2008; 180(3): 1991 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ghose, A. Kalsy, A. Sheikh, J. Rollenhagen, M. John, J. Young, S. M. Rollins, F. Qadri, S. B. Calderwood, C. P. Kelly, et al. Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice Infect. Immun., June 1, 2007; 75(6): 2826 - 2832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Zoeteweij, D. E. Epperson, J. D. Porter, C. X. Zhang, O. Y. Frolova, A. P. Constantinides, S. R. Fuhrmann, M. El-Amine, J.-H. Tian, L. R. Ellingsworth, et al. GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant J. Immunol., July 15, 2006; 177(2): 1197 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Godefroy, M. Peyre, N. Garcia, S. Muller, D. Sesardic, and C. D. Partidos Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin Infect. Immun., August 1, 2005; 73(8): 4803 - 4809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Eriksson, K. M. Schon, and N. Y. Lycke The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues J. Immunol., September 1, 2004; 173(5): 3310 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guebre-Xabier, S. A. Hammond, L. R. Ellingsworth, and G. M. Glenn Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice J. Virol., July 15, 2004; 78(14): 7610 - 7618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Lavelle, A. Jarnicki, E. McNeela, M. E. Armstrong, S. C. Higgins, O. Leavy, and K. H. G. Mills Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent J. Leukoc. Biol., May 1, 2004; 75(5): 756 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Riminton, R. Kandasamy, D. Dravec, A. Basten, and A. G. Baxter Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease J. Immunol., January 1, 2004; 172(1): 302 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guebre-Xabier, S. A. Hammond, D. E. Epperson, J. Yu, L. Ellingsworth, and G. M. Glenn Immunostimulant Patch Containing Heat-Labile Enterotoxin from Escherichia coli Enhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic Cells J. Virol., May 1, 2003; 77(9): 5218 - 5225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-S. Beignon, J.-P. Briand, R. Rappuoli, S. Muller, and C. D. Partidos The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin Infect. Immun., June 1, 2002; 70(6): 3012 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Guerena-Burgueno, E. R. Hall, D. N. Taylor, F. J. Cassels, D. A. Scott, M. K. Wolf, Z. J. Roberts, G. V. Nesterova, C. R. Alving, and G. M. Glenn Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously Infect. Immun., April 1, 2002; 70(4): 1874 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Fuller, P. A. Rajakumar, L. A. Wilson, A. M. Trichel, J. T. Fuller, T. Shipley, M. S. Wu, K. Weis, C. R. Rinaldo, J. R. Haynes, et al. Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine J. Virol., March 7, 2002; 76(7): 3309 - 3317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yu, F. Cassels, T. Scharton-Kersten, S. A. Hammond, A. Hartman, E. Angov, B. Corthesy, C. Alving, and G. Glenn Transcutaneous Immunization Using Colonization Factor and Heat-Labile Enterotoxin Induces Correlates of Protective Immunity for Enterotoxigenic Escherichia coli Infect. Immun., March 1, 2002; 70(3): 1056 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, S. B. Periwal, K. Larrivee, C. Zuleger, C. A. Erickson, R. L. Endres, and L. G. Payne Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization J. Virol., September 1, 2001; 75(17): 7956 - 7965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Scharton-Kersten, J.-m. Yu, R. Vassell, D. O'Hagan, C. R. Alving, and G. M. Glenn Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants Infect. Immun., September 1, 2000; 68(9): 5306 - 5313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Committee on Infectious Diseases, 1998MIHNEAndash1, Ex-Officio, and L. Representatives Combination Vaccines for Childhood Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) Pediatrics, May 1, 1999; 103(5): 1064 - 1077. [Full Text]
|
|
|
|
|
|
G. M. Glenn, T. Scharton-Kersten, R. Vassell, G. R. Matyas, and C. R. Alving Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants Infect. Immun., March 1, 1999; 67(3): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
